Learn R Programming

metamedian (version 1.2.1)

dat.lung: Example data set: Overall survival times in patients with lung cancer

Description

A data set based on a meta-analysis comparing overall survival times between individuals randomized to experimental arms and comparator arms in randomized trials for non-small cell lung cancer therapies (Iskander et al. 2024).

Usage

dat.lung

Arguments

Format

A data frame with 30 rows and 11 columns:

studyNational Clinical Trial (NCT) number of the study.
n.g1number of subjects (experimental group).
med.g1median overall survival (experimental group).
med.ci.lb.g1lower confidence interval bound around the median (experimental group).
med.ci.ub.g1upper confidence interval bound around the median (experimental group).
med.ci.level.g1level of the confidence interval (experimental group).
n.g2number of subjects (comparator group).
med.g2median overall survival (comparator group).
med.ci.lb.g2lower confidence interval bound around the median (comparator group).
med.ci.ub.g2upper confidence interval bound around the median (comparator group).
med.ci.level.g2level of the confidence interval (comparator group).

References

Iskander, R., Moyer, H., Fergusson, D., McGrath, S., Benedetti, A., and Kimmelman, J. (2024). The benefits and risks of receiving investigational solid tumor drugs in randomized trials: A systematic review and meta-analysis. Annals of Internal Medicine. 177(6)759-767.